A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX

NCT00314145 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

820

Enrollment

INDUSTRY

Sponsor class

Conditions

Japanese Encephalitis

Interventions

BIOLOGICAL: ChimeriVax™-JE
BIOLOGICAL: JE-VAX®

Sponsor

Sanofi